Monte Rosa Therapeutics Inc (GLUE) — Capital Reinvestment Ratio
Monte Rosa Therapeutics Inc (GLUE) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow ($100.43 Million) in capital expenditures ($651.00K). See GLUE net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Monte Rosa Therapeutics Inc Capital Reinvestment Ratio (2024–2024)
This chart tracks Monte Rosa Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check Monte Rosa Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Monte Rosa Therapeutics Inc (2024–2024)
Year-by-year Capital Reinvestment Ratio for Monte Rosa Therapeutics Inc from 2024 to 2024. For live market cap and broader valuation context, see Monte Rosa Therapeutics Inc (GLUE) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | $42.00 Million | $3.99 Million | — |